For example, agonists to glucagon-like peptide 1 (GLP-1), a hormone produced by intestinal cells called enteroendocrine cells (EECs), revolutionised type II diabetes mellitus and obesity treatment [14]. This evidence concerns the gene GCG and obesity disorder.